0001725160-23-000172.txt : 20231004
0001725160-23-000172.hdr.sgml : 20231004
20231004202853
ACCESSION NUMBER: 0001725160-23-000172
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231004
DATE AS OF CHANGE: 20231004
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001725160
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823607803
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39263
FILM NUMBER: 231309566
BUSINESS ADDRESS:
STREET 1: 1359 BROADWAY, SUITE 801
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: (212) 433-3791
MAIL ADDRESS:
STREET 1: 1359 BROADWAY, SUITE 801
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20200107
FORMER COMPANY:
FORMER CONFORMED NAME: Zeno Pharma, LLC
DATE OF NAME CHANGE: 20171212
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Brownstein Carrie
CENTRAL INDEX KEY: 0001894232
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 500 W. 5TH ST.
STREET 2: SUITE 1200
CITY: AUSTIN
STATE: TX
ZIP: 78701
144
1
primary_doc.xml
144
0001894232
XXXXXXXX
LIVE
0001725160
Zentalis Pharmaceuticals, Inc.
001-39263
1359 BROADWAY, SUITE 801
New York
NY
10018
212-433-3791
Carrie Brownstein
Chief Medical Officer
Common
Morgan Stanley Smith Barney LLC
1 New York Plaza, 38th Floor
New York
NY
10004
10628
207298.08
70749040
10/04/2023
NASDAQ
Common
10/03/2023
Restricted Stock Unit Release
Issuer
N
10628
10/03/2023
NA
Y
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that she does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
10/04/2023
12/03/2022
/s/ Melissa Epperly, attorney-in-fact for Carrie Brownstein